Vlatko Pejša

Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia

Courtney D. DiNardo, Brian A. Jonas, Vinod Pullarkat et al. · New England Journal of Medicine · 2020 · 2.6K citations · Full text

Assessing serum albumin concentration, lymphocyte count and prognostic nutritional index might improve prognostication in patients with myelofibrosis

Marko Lucijanić, Ivo Veletić, Dario Rahelić et al. · Wiener klinische Wochenschrift · 2018 · 37 citations · Full text

Hematological Malignancy, Prognostic Evaluation, Prognostic Nutritional Index +7

Elevated Neutrophil–to–Lymphocyte-ratio and Platelet–to–Lymphocyte Ratio in Myelofibrosis: Inflammatory Biomarkers or Representatives of Myeloproliferation Itself?

Marko Lucijanić, David Čičić, Tajana Štoos‐Veić et al. · Anticancer Research · 2018 · 34 citations · Full text

Venetoclax combinations delay the time to deterioration of HRQoL in unfit patients with acute myeloid leukemia

Keith W. Pratz, Panayiotis Panayiotidis, Christian Récher et al. · Blood Cancer Journal · 2022 · 32 citations · Full text

The Degree of Anisocytosis Predicts Survival in Patients with Primary Myelofibrosis

Marko Lucijanić, Vlatko Pejša, Ozren Jakšić et al. · Acta Haematologica · 2016 · 25 citations

Anisocytosis Predicts Survival, Immunohematology, Immunology +20